Ariel Alonso

发表

A perspective on surrogate endpoints in controlled clinical trials

G. Molenberghs, M. Buyse, A. Alonso, 2004, Statistical methods in medical research.

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials

G. Molenberghs, M. Buyse, A. Alonso, 2010, Statistical methods in medical research.

INVESTIGATING THE CRITERION VALIDITY OF PSYCHIATRIC SYMPTOM SCALES USING SURROGATE MARKER VALIDATION METHODOLOGY

Geert Molenberghs, Helena Geys, Tony Vangeneugden, 2002, Journal of biopharmaceutical statistics.

Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial

G. Molenberghs, A. Alonso, K. Andries, 2018, PloS one.

Applied Surrogate Endpoint Evaluation Methods with SAS and R

Ariel Alonso, A. Alonso, Ariel Alonso, 2016 .

Information Theory–Based Surrogate Marker Evaluation from Several Randomized Clinical Trials with Binary Endpoints, Using SAS

Geert Molenberghs, Abel Tilahun, Assam Pryseley, 2008, Journal of biopharmaceutical statistics.

Evaluating time to cancer recurrence as a surrogate marker for survival from an information theory perspective

Geert Molenberghs, Ariel Alonso, G. Molenberghs, 2008, Statistical methods in medical research.

Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpoints

Geert Molenberghs, Abel Tilahun, Assam Pryseley, 2007, Clinical trials.

Surrogate Marker Evaluation from an Information Theory Perspective

G. Molenberghs, A. Alonso, Ariel Alonso, 2007, Biometrics.

Prentice's Approach and the Meta‐Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints

Geert Molenberghs, Ziv Shkedy, José Cortiñas Abrahantes, 2004, Biometrics.

Statistical challenges in the evaluation of surrogate endpoints in randomized trials.

Geert Molenberghs, Tomasz Burzykowski, Helena Geys, 2002, Controlled clinical trials.

Genomic Biomarkers for Depression: Feature-Specific and Joint Biomarkers

Hinrich W. H. Göhlmann, G. Molenberghs, Z. Shkedy, 2010 .

A reflection on the causal interpretation of individual-level surrogacy

G. Molenberghs, W. Van der Elst, Ariel Alonso, 2019, Journal of biopharmaceutical statistics.

Statistical evaluation of surrogate endpoints with examples from cancer clinical trials

Geert Molenberghs, Tomasz Burzykowski, Marc Buyse, 2016, Biometrical journal. Biometrische Zeitschrift.

Estimation After a Group Sequential Trial

Geert Molenberghs, Geert Verbeke, Marie Davidian, 2014, Statistics in Biosciences.

Coping With Memory Effect and Serial Correlation When Estimating Reliability in a Longitudinal Framework

G. Molenberghs, A. Laenen, C. Mallinckrodt, 2010 .

Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.

G. Molenberghs, A. Alonso, A. Laenen, 2009, Journal of psychiatric research.

Reliability of a Longitudinal Sequence of Scale Ratings

G. Molenberghs, A. Alonso, A. Laenen, 2009 .

A family of measures to evaluate scale reliability in a longitudinal setting

Geert Molenberghs, Annouschka Laenen, Tony Vangeneugden, 2009 .

Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of caution

G. Molenberghs, G. Verbeke, A. Alonso, 2021, Journal of biopharmaceutical statistics.

A reflection on the possibility of finding a good surrogate

Geert Molenberghs, Geert Verbeke, Ariel Alonso, 2019, Journal of biopharmaceutical statistics.

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

G. Molenberghs, L. Sanchez, A. Lage, 2019, BMC Cancer.

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials

G. Molenberghs, M. Buyse, T. Burzykowski, 2010, Statistical methods in medical research.

Rejoinder to “A Note on Type II Error Under Random Effects Misspecification in Generalized Linear Mixed Models”

G. Molenberghs, S. Litière, Ariel Alonso, 2010 .

The impact of a misspecified random‐effects distribution on the estimation and the performance of inferential procedures in generalized linear mixed models

G Molenberghs, G. Molenberghs, S. Litière, 2008, Statistics in medicine.

Type I and Type II Error Under Random‐Effects Misspecification in Generalized Linear Mixed Models

Geert Molenberghs, Ariel Alonso, Saskia Litière, 2007, Biometrics.

Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules.

Geert Molenberghs, Geert Verbeke, Marie Davidian, 2016, Journal of biometrics & biostatistics.